£2.9bn
£XXX.Xm
9,458
247
£XXX.Xm
Basic pharmaceutical product manufacturing is an integral part of the pharmaceutical supply chain and the pharmaceutical sector's research and development process. Over the five years through 2024-25, industry revenue is expected to increase at a compound annual rate of 3.7% to reach £2.9 billion, including forecast growth of 5.9% in 2024-25. Sales have been supported by pharma companies modernising their manufacturing processes and rationalising their product portfolios. Despite this, many multinationals have continued to offshore production to developing countries with lower costs, holding revenue back.
Industry revenue has grown at a CAGR of 3.7 % over the past five years, to reach an estimated £2.9bn in 2024.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2025 | Revenue (£m)
2025 |
---|---|---|
Sterling Pharma Solutions Ltd | 111.6 | |
Accord-UK Ltd | 110.5 | |
Sandoz Ltd | 89.8 |
To view the market share and analysis for all 5 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Human and animal blood processing, Other and Chemically pure sugars. Human and animal blood processing is the largest segment of the Basic Pharmaceutical Product Manufacturing in the UK.
Rising raw material costs hit active pharmaceutical ingredient (API) makers
Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry also includes companies that manufacture chemically pure sugars and process blood and glands.
Purchase this report to view all 5 major companies in this industry.
SIC 21.10 - Basic Pharmaceutical Product Manufacturing in the UK
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
COVID-19 drives demand for blood processing and APIs. The pandemic gave demand for blood samples a huge boost – they were needed for antibody tests. Vaccine manufacturing fur...
Learn about an industry's products and services, markets and trends in international trade.
Rising costs put a denting in API manufacturing. Escalating energy expenses and supply chain disruptions resulting from the Russia-Ukraine conflict have hiked raw material co...
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
London attracts pharmaceutical manufacturers. Its infrastructure, robust healthcare system, world-class universities for research and supportive government policies make it a...
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Patent protection gives pharmaceutical producers an edge. It grants them the rights to exclusively produce, use and sell a newly developed drug, encouraging innovation while ...
Learn about the performance of the top companies in the industry.
AstraZeneca wins big during the pandemic. The company, in partnership with Oxford University, has manufactured and supplied over two billion COVID-19 vaccine doses worldwide,...
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
The Medicines Act shapes pharma companies' operations. The law demands high standards for safety, quality and efficacy, requiring pharma companies to invest heavily in testin...
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Rising costs dent pharma companies’ returns. Increased overheads and fierce pricing pressures from overseas competitors have slashed the average industry margin in recent yea...
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the UK include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Basic Pharmaceutical Product Manufacturing in the UK industry in United Kingdom is £2.9bn in 2024.
There are 247 businesses in the Basic Pharmaceutical Product Manufacturing in the UK industry in United Kingdom, which has grown at a CAGR of 3.7 % between 2019 and 2024.
The market size of the Basic Pharmaceutical Product Manufacturing in the UK industry in United Kingdom has been growing at a CAGR of 3.7 % between 2019 and 2024.
Over the next five years, the Basic Pharmaceutical Product Manufacturing in the UK industry in United Kingdom is expected to grow.
The biggest companies operating in the Basic Pharmaceutical Product Manufacturing market in United Kingdom are Sterling Pharma Solutions Ltd, Accord-UK Ltd and Sandoz Ltd
Human and animal blood processing and Chemically pure sugars are part of the Basic Pharmaceutical Product Manufacturing in the UK industry.
The company holding the most market share in United Kingdom is Sterling Pharma Solutions Ltd.
The level of competition is high and steady in the Basic Pharmaceutical Product Manufacturing in the UK industry in United Kingdom.